LMO법에 따른 연구시설의 운영 및 시험연구용 LMO의 관리 = Guideline for managing research facilities and LMOs for R&D by the Act on transboundary movement of LMOs, etc,.

다국어 초록 (Multilingual Abstract)

The transgenic technologies and their product (living modified organisms) have been developed
and commercialized enough to get much attention in terms of their potentials to solve the current global
difficulties such as shortage of food and energy. Furthermore, they are expected to make a big role in
improving human health levels and creating bio-economy as innovative tools to pursue environmentally sound
economic development. However, for the technologies and products to be developed and used in such a way
that they continuously give a good impact to human society, first and foremost safety issues surrounding
them should be dealt with. Every stage from in-house R&D, pilot field application to on the shelves should
be managed to ensure safety following them because many consumers tend to have fear before they get the
right or needed information on the modern biotechnology. In this sense, managing research facilities and
LMOs for R&D from the point of safety is very crucial in that they are in the early stage of technology or
product development. This paper especially deals with those to be complied with by researchers according
to the Act on transboundary movement of LMOs, etc, entered into the effect from Jan. 1 2008.

다국어 초록 (Multilingual Abstract)

The transgenic technologies and their product (living modified organisms) have been developed
and commercialized enough to get much attention in terms of their potentials to solve the current global
difficulties such as shortage of food and energy. Furthermore, they are expected to make a big role in
improving human health levels and creating bio-economy as innovative tools to pursue environmentally sound
economic development. However, for the technologies and products to be developed and used in such a way
that they continuously give a good impact to human society, first and foremost safety issues surrounding
them should be dealt with. Every stage from in-house R&D, pilot field application to on the shelves should
be managed to ensure safety following them because many consumers tend to have fear before they get the
right or needed information on the modern biotechnology. In this sense, managing research facilities and
LMOs for R&D from the point of safety is very crucial in that they are in the early stage of technology or
product development. This paper especially deals with those to be complied with by researchers according
to the Act on transboundary movement of LMOs, etc, entered into the effect from Jan. 1 2008.

참고문헌 (Reference)

1 Korea Biosafety Clearing-House, "The law on transboundary movement, etc. of LMOs" Korea Biosafety Clearing-House 2007

2 Yoshikura H., "The guidance on the biosafety protocol for researcher - basic rules before the experiment on LMO" 2006

3 Rural Development Administration, "Regulations relating to convention on biological diversity" Rural Development Administration 2005

4 Korea Biosafety Clearing-House, "Guidance on biosafety" Korea Biosafety Clearing-House 2006

5 Korea Biosafety Clearing-House, "Cartagena protocol on biosafety and the law on transboundary movement, etc. of LMOs (LMO law)" Korea Biosafety Clearing-House 2002

6 Mackenzie R., "An explanatory guide to the Cartagena protocol on biosafety" IUCN 2003

7 Kim H. K., "A Study on the policy agenda setting of bioethics in Korea" Korea University 2002

8 Korea Biosafety Clearing-House, "2006 Biosafety white paper" Korea Biosafety Clearing-House 2007